In this section,
I want to indicate the pivotal role of the intestine in health and disease.
The whole alimentary
tract is the place for eating, chewing, swallowing, mixing, digesting,
absorbing, fermenting, secreting and/or eliminating the various substances
that it encounters.
It is certainly
a crucial immune organ, and I place much emphasis on the intestinal
flora (the bacteria which inhabit the intestine, particularly the large
intestine).
Research is needed
to clarify more details of what nutritional physicians and naturopaths
call the "leaky gut syndrome". It is supposed that some low-grade
inflammatory processes lead to dysfunction of gut cells.
In essence we really
need to know whether there are circumstances of decreased synthesis
of specific amino acids by gut flora and we need to have objective studies
of the degree to which intestinal cells can consume amino acids.
If in addition protein
catabolism in C.F.S. exceeds protein availability, the host is compromised.
The Newcastle group
claim to identify some of these patterns.
a) Short term
protein catabolism involves non-fibrillar or cytoplasmic proteins
from muscle broken down to release tyrosine. The amino acid leucine
controls non fibrillar proteolysis in muscle and adipose tissue. Thus
alteration in leucine metabolism could contribute to this proteolysis
in C.F.S.
b) Long term protein
catabolism. Here contractible muscle elements (actin and myosin) are
broken down releasing 3-methyl histidine.
The Newcastle group
measure this in urine, along with many amino acids, serine, alanine,
glycine, valine, threonine, leucine and asparagine and find many of
these amino acids to be low in C.F.S.
Why they chose to
measure urinary amino acids is unclear. It would seem to be more logical
to measure blood levels. Some of the amino acids which they report as
low in the urine are actually non-essential amino acids (meaning that
the body can synthesize them) (e.g. serine, alanine and glycine).
The general principles
behind assessing the meaning of any bodily chemical change include the
following.
DEFICIENCIES.
Low levels of amino
acids such as serine in the urine could reflect:
a) A very low
protein diet.
b) Under-production
by intestinal flora.
c) Consumption
by intestinal cells.
d) Impairment
of synthesis since serine is normally synthesized from glucose.
e) Excessive conversion
to something else.
f) Excessive consumption
by some other cellular system. (This might be feasible if other metabolic
pathways are blocked or inefficient.)
EXCESSES.
High levels of amino
acids might result from:
a) Very high protein
intake.
b) Over-production
by intestinal flora.
c) Breakdown of
cells which contain this amino acid.
d) Blocked conversion
to something else.
Some amino acids
which appear in high amounts in their tests, might indeed signify muscle
catabolism.
Can we distinguish
between these and those that are the result of meat/flesh consumption?
What is really needed
is clarification of the relationship between blood and tissue levels
of amino acid and these urinary levels.
More recently the
Newcastle Group have clustered the amino acids according to function.
e.g. High hippurate
excretion could indicate a high liver detoxification rate and an increased
requirement for glycine. (Could supplements of serine, glycine, glutamine
or glutathione help?)
ORGANIC ACIDS.
One of the commonest
findings is a high urinary citrate level (often ten times higher than
in control subjects). High urinary citrate could imply over-production
of citrate or blockage in the Krebs cycle (named after Sir Hans Krebs),
also called the tricarboxylic acid cycle (TCA)
Paul Cheney writes
that blood citrate levels are elevated.
This finding invites
a close look at this basic cell energy cycle.
If one crucial part
of CFS is inability to replenish adenosine triphosphate(the stored energy
source, we could explain post exercise fatigue, as well as poor concentration
and thinking.
ATP is the product
of the Krebs cycle, or tricarboxylic acid cycle.
THE KREBS CYCLE
(TCA)
The fundamental
pathways of fat, carbohydrate, protein and ketone oxidation result in
a 2-carbon acetyl portion of acetyl coenzyme A.
One of the main
sources of acetyl CoA for the TCA is pyruvate formed from glucose in
the glycolytic pathway.
Pyruvate is oxidized
to acetyl CoA by the pyruvate dehydrogenase complex. (PDHase)
This enzyme is in
the same family as the alpha ketoglutatarate dehydrogenase complex,
but differs by containing additional subunits, one of which is a protein
kinase called pyruvate dehydrogenase kinase.
This phosphorylates
the PDHase into an inactive form.
There may be a subgroup
of CFS cases who form lactic acid more readily, because of impaired
PDHase.
Another regulatory
subunit is a phosphatase which removes the phosphate residue . This
is stimulated by increased intracellular Ca++.
Insulin binds to
its receptor on the plasma membrane and this somehow activates PDHase.
In the Krebs or
tricarboxylic acid cycle, this acetyl fragment is further oxidized to
CO2.
This cycle is located
in the mitochondria of cells, and accounts for some 80% of cell energy.
The cycle of organic
acids Oxaloacetic acid-àcitric acid--àisocitric acid--àalpha
ketoglutaric acid-à succinylCoA --àsuccinic acid--àfumaric
acid--àmalic acid---àoxaloacetate involves enzymes, electron
transfers through electron accepting coenzymes and a way of cells capturing
energy for their specific functions, and giving off carbon dioxide (CO2).
The captured energy
is in the production of ATP.
Most of the enzymes
of the TCA are synthesized in the nucleus and imported into mitochondria
by special mechanisms, requiring considerable energy.
We already know
that some vitamin deficiencies such as thiamine deficiency result in
dysfunctional enzymes such as pyruvate dehydrogenase and alpha keto
glutarate dehydrogenase.
Dr Paul Cheney in
North Carolina reports that he measures organic acids in both blood
and urine, and finds high levels of citrate in subjects with chronic
fatigue. This could suggest that the further conversion to isocitrate
and alpha keto glutarate is impaired.
The enzyme conversions
in these sites are
1) Aconitase,
which turns the citric acid into cis aconitic acid and isocitric acid.
This enzyme has thiol groups, which could be protected by glutathione
and also needs non-haem iron.
It is interesting
that aconitase is inhibited by nitric oxide and also by its condensation
with superoxide to form peroxynitrite (PON).
Peroxynitrite
(PON) also inhibits complexes I, II and V (the ATP synthase) aconitase,
creatine kinase, and increases the proton leak in isolated mitochondria
in some cultured cell models. We will address other actions of PON
in discussing cytokines in more detail.
(2) The
next enzyme in the TCA cycle is isocitrate dehydrogenase, which oxidizes
the alcohol group on the isocitric acid to a keto group. It is influenced
by Ca++, Mn++ and Mg++ and is stimulated by AMP and ADP, and inhibited
by NADH.
At this step,
the added hydrogen as hydride ( NAD+to NADH), allows the NADH to donate
an electron to the electron transport chain.
(3) Of
interest is the next step from a ketoglutaric acid to succinyl CoA.
The a ketoglutaric
dehydrogenase complex (a triple enzyme complex) consists of a ketoglutarate
dehydrogenase (decarboxylase), transsuccinylase and lipoamide dehydrogenase.
It uses thiamine
pyrophosphate, lipoate and FAD. Again NAD+ is reduced to NADH.
(FAD and NAD+ are
the electron acceptors in the Krebs cycle.)
This complex has
similar susceptibilities to peroxynitrite as do aconitase and pyruvate
dehydrogenase.
The energy of the
succinyl CoA thioester bond is used to generate GTP from GDP and Pi
in the reaction catalysed by succinate thiokinase, also called succinyl
CoA synthetase.
The exact details of the production of available energy stores for the
cell are fascinating and the electron acceptors donate their electrons
to co-enzyme Q10 located in the inner mitochondrial membrane.
The electron transport
chain gives rise to the phosphorylation of ADP to ATP.
The electron transport
system is organized into 3 main membrane-spanning complexes,
Complex I, NADH
dehydrogenase, (with Co-enzyme Q10 as electron acceptor then donor)
Complex III,
the cytochrome b-c1 which accepts the electrons from the CoE Q10,
and
Complex IV,
cytochrome oxidase, which contains the binding, site for oxygen.
Oxidative phosphorylation
consists of five protein-lipid enzyme complexes located in the mitochondrial
inner membrane that contain flavins (FMN,
FAD), quinoid compounds (coenzyme Q10, CoQ10) and transition metal compounds
(iron-sulfur clusters, hemes, protein-bound copper).
In more detail,
these enzymes are designated
(1) complex I (NADH:ubiquinone oxidoreductase,),
(2) complex II (succinate:ubiquinone oxidoreductase,),
(3) complex III (ubiquinol:ferrocytochrome c oxidoreductase,)
(4) complex IV
(ferrocytochrome c:oxygen oxidoreductase or cytochrome c oxidase,),
and
(5) complex V (ATP synthase,).
To summarize,
This is called the electron transport chain, NADH dehydrogenase (complex
1)is the first step, then Coenzyme Q10 which transports electrons, to
the cytochrome b-c1(Complex 3), cytochrome c (a small protein) and cytochrome
oxidase(Complex 4), and ATP synthase.
Co E Q10 has 2 electrons to donate so can replenish oxidized tocopherols,
and shuttles between the ubiquinone and ubiquinol forms,(I have a monograph
on CoE Q10) as can alpha lipoic acid.
I should mention that mitochondrial DNA is 10 times as susceptible to
free radical injury as intra-nuclear DNA
As electrons are
transferred through each of the 3 membrane spanning complexes, protons
are pumped from the mitochondrial matrix to the cytosolic side of the
inner mitochondrial membrane.
There are chemo-osmotic
theories about how the energy from this electron transport is transformed
into the high energy phosphate bonds of ATP, but perhaps these can be
left to the interested reader to find in modern biochemistry textbooks.
If the CFS sufferer
spends energy faster than the mitochondria can supply it, (and most
CFS sufferers are doing this most of the time!) ATP is converted to
ADP faster than it can be recycled. This means there is a build up of
ADP. Some ADP is inevitably shunted into adenosine monophosphate (AMP
-1 phosphate). But this creates a real problem, indeed a metabolic disaster,
because AMP, largely speaking, cannot be recycled and is lost in urine.
If ATP levels drop
as a result of leakage of AMP, the body then has to make brand new ATP.
ATP can be made very quickly from a sugar D-ribose, but D-ribose is
only slowly made from glucose (via the pentose phosphate.
(Any modern biochemistry
text will do, but I am drawing upon Chapter 20 of Basic Medical Biochemistry,
Marks, Marks and Smith 1996)
It remains crucial
to discover which of these processes are most susceptible to injury.
As mentioned, aconitase
and alpha ketoglutarate dehydrogenase, appear to be susceptible to free
radical injury.
Isocitrate dehydrogenase
and alpha ketoglutarate dehydrogenase are rate limiting in the TCA.
Both appear to be activated by calcium ions (Ca++)
Since I draw upon
this material for my plan of helping cellular energy, I want the reader
to consider the following information.
Glutathione
Dr Cheney suggests
that the primary cause of citrate elevation is glutathione deficiency.
This would need some substantiation.
In the CFS cases
that have the abnormal 37 kDa form of RNAse L, the glutathione system
may be damaged
Glutathione (GSH)
(Gamma-glutamylcysteinylglycine) is a tripeptide of glutamine, cysteine,
and glycine.
There is a gamma
glutamyl cycle involving amino acid transport into certain types of
cells.
Glutathione reduces
free radical damage by reducing compounds such as hydrogen peroxide.
It protects the sulphydryl (thiol) groups on the aconitase and also
other thiol containing enzymes and cofactors.
The glutathione
sulphydryl groups serve as electron donors, and are oxidized to a disulphide
form (GSSG).
Once the disulphide
is formed it must be reduced back to the sulphydryl form by glutathione
reductase, which requires electrons from NADPH (generated from the pentose
phosphate pathway)
GSH appears to be
involved in recycling vitamins E, C, coenzyme Q10 and alpha lipoic acid.
Whey proteins contain
serum albumin. alpha lactalbumin, and lactoferrin, (all rich in cystine)
but do not contain lactose or casein.
One brand (Pharmafood)
is called IsoWhey.
Almost 30% of the
Iso Whey proteins contain branch chain amino acids
(Leucine, isoleucine
and valine)
The Newcastle group
claim that low leucine in the unexercised CFS patient denotes impaired
regulation of muscle catabolism.
Leucine can be lost
in exercise by increased action of branch chain keto-acid dehydrogenase.
Particular products
may have advantages.
Dr Robert Buist
says that Pharmafoods Iso-Whey contains approximately 32% of the
3 cystine rich proteins.
He says that the
cystine in whey is more able to avoid hydrolysis in the gut, and inside
the cell liberates 2 molecules of L-cysteine, and this drives the synthesis
of glutathione.
At least some people
with chronic fatigue also have low urinary levels of alpha ketoglutarate,
or low succinate levels (further around the Krebs cycle).
So is the glutathione
low and if so why is it? At least some may be associated with low glycine,
and perhaps some with low glutamine, and now we have evidence of the
question of active mechanisms which might deplete it.
Cheney explains
that some viruses when activated encode genes for glutathione peroxidase
which will deplete selenium, as selenoproteins are needed for viral
replication.
These include HIV,
E-B virus and presumably other herpes like viruses, as well as hepatitis
B and C.
For our cells glutathione
peroxidase is one of the bodys principal ways of protecting us
from free radical damage.
One of the two glutathione
peroxidases requires selenium for its function.
Cheney says that
glutathione has antiviral activity.
Cheney says that
the elevated citrate level lowers the level of 2,3 diphosphoglycerate
(2,3DPG), which in turn makes it harder for haemoglobin (Hb) to give
up its oxygen to tissue cells.
It is well established
that 2,3 DPG is needed for haemoglobin to release O2 in low O2 tension
sites.
The tissue hypoxia
would increase the tendency to increase lactic acid.
This could set up
intracellular acidosis, and a compensatory blood alkalosis, as well
as further compromising the Krebs cycle
He suggests supplements
of glutathione as whey protein, and inhalation of oxygen for 20 minutes
three times per day. (In specific circumstances)
Newcastle researchers
suggest increased urinary loss of cations such as sodium (Na+, potassium
(K+) and magnesium (Mg++) would be enhanced by high urinary citrate.
Low sodium might
account for some part of the reduced blood volume reported by David
Bell and Peter Rowe, and low potassium the 50% of CFS with low total
body potassium reported by Dr Richard Burnet.
Burnet also describes
a subgroup with high total body potassium.
We need some studies
to check whole body magnesium to clarify the comments on the need for
magnesium by such people as Dr Paul Cheney.
Roberts and colleagues
in Newcastle NSW have discussed the concept of channelopathy
and Dr Donald Lewis in Victoria reports success by using lamotrigine,
which acts on sodium/potassium channels.
If selenium is also
lost or deficient, the selenium dependent glutathione peroxidase would
not work efficiently, and this could disadvantage the high oxygen sites
such as red blood cells.
The Newcastle group
suggest very high levels of lysine are found in about 10% of CFS cases
and that this correlates with neurally mediated hypotension and perhaps
persistent infections and ANA levels.
Mention needs to
be made of urine metabolites (UM), which are detected in Newcastle screens
but have not been fully characterized.
The researchers
say that CFS UM1 correlates with high levels of 3-methyl histidine and
also correlates with increased symptom expression such as cognitive
changes, musculo-skeletal symptoms, infective symptoms and increased
somatization scores in psychological testing.
They associate UM15
with depressive scores and UM's 13, 13A, 15A, 27 and 28 with carriage
of toxin producing coagulase negative staphylococci.
We need to have
these chemicals identified, and understand their functions.
The Newcastle group
is doing this.
As well blood and
tissue levels are probably more important than urinary levels, and the
work needs independent evaluation.
Kuratsune and colleagues
in Osaka, Japan report low levels of acyl carnitine in CFS and hepatitis
C.
Insulin and hyperinsulinaemia.
There appear to
be genes which increase the risk of developing insulin resistance.
With such genes,
caloric excess, dietary obesity and particular food eating patterns
appear to increase the risk of pancreatic beta cells making too much
insulin.
This can drive increased
sympathetic activity which can predispose to feeling unwell, and ultimately
increase the risk of hypertension.
Insulin has a principal
function in promoting and allowing glucose to enter cells, an done part
of this is to allow fat cells to receive the glucose.
But excess insulin
can increase the amount of fat.
In normal circumstances,
a product of fat cells called leptin, signals the hypothalamus to stop
the person continuing to feel hungry.
But there can arise
leptin resistance, where the person continues to feel like eating.
Recent evidence
has suggested that modern man is at high risk to eat too many calories,
the wrong kind of food, and at the same time exercise too little.
One adverse effect
of food manufacturers adding sucrose (cane sugar), or fructose
(Eg in corn syrup)
is the risk that modern man eats too much fructose.
Now fructose can
only really be used by the liver, and if given in excess, is toxic to
the liver,
It
(1) Increases
phosphate depletion in liver cells.
(2) Increases
uric acid.
(3) Allows increase
in nitric oxide which helps keep BP down.
(4) Initiates
de novo lipogenesis, and increases LDL (sometimes called bad
cholesterol)
(5) Increases
c jun terminal kinases which increases inflammation.
A proportion of
persons develop fatty liver when this situation prevails.
Thus hyperinsulinaemia,
leptin resistance contribute to people feeling unwell, anxious, fatigued
and even achy.
One remedy is exercise
since this
(1) Increases
skeletal muscle insulin sensitivity.
(2) Reduces cortisol
levels.
(3) Decreases
visceral fat that results from too much cortisol.
(4) Helps detoxify
fructose.
This will work even
better when calories are decreased to balance energy expenditure ,fructose
and sucrose intakes are reduced, fibre intake is increased, and the
total glycaemic load is reduced.
In fact most fructose
containing fruits are much safer when eaten as whole fruit .Juice intake
needs to be minimized.
Sleep disorders.
We cannot leave
metabolic disorders without paying attention to some of the consequences
of disordered sleep.
Impaired sleep is
suggested by the presence of any of the following,
(1) Snoring,
(2) Sleep apnoea
(breathing stops repeatedly during sleep)
(3) Sleep deprivation,
(4) Shift work
and altered sleep rhythms,
(5) Experience
that sleep is unrefreshing,
(6) Excessive
daytime sleepiness, and tendencies to drop off to sleep in daytime
activities.
The metabolic changes
include, lack of oxygen during apnoea (hypoxaemia,) with marked sympathetic
responses that can generate high blood pressure and increase the risk
of cardiac events.
The more severe
sleep disorders may increase a hormone called Grhelin, increased insulin
release, and resistance to insulin and leptin.
The person may eat
more in these states. In some cases there is increased obesity, and
an increased risk of diabetes.
This may become
a vicious cycle.
There is a risk
of increased accident rates while driving or at work.
Molybdenum
Molybdenum (Mo)
appears to protect people from oesophageal cancer.
It is necessary
for the activity of sulphite and xanthine oxidase, and aldehyde oxidase.
In all molybdenum-containing
enzymes with the exception of nitrogenase, the molybdenum cofactor (Moco)1
consists of a mononuclear Mo atom coordinated to the cis-dithiolene
moiety of molybdopterin (MPT).
The metabolic pathway
that shows the likely cause of aldehyde protection is--
Threonine or Ethanol-->
aldehyde--> acetic acid--> acetyl coenzyme A.
A toxin, acetaldehyde,
can be transformed into a source of energy, acetyl coenzyme A provided
there is adequate molybdenum in the diet or through supplement form.
Thus this claim
is correct if Mo was low. Can extra Mo protect?
Molybdenum is usually
found in milk, lamb, pork, beans, lentils, peas, soybeans and some seeds,
including oats and wheat germ.
If a soil was deficient,
the plant would have less Mo.
What is the RDA?
Average USA intakes
vary from 120-240mcg/day.
I seems to be safe
to add 100-200mcg /day as a supplement for a month to assess the response.
Eagle Tresos
B has 46.6mcg per tablet, and Bioceuticals Ultramuscleze
powder has 60mcg per teaspoon.
One could suggest
that people who are chemically sensitive might find Mo could decrease
reactions to formaldehyde in carpets and metabisulphite in dried fruits
and wines.
There are some claims
that Mo can help chronic fatigue syndromes, fibromyalgia and post polio
syndromes at doses of 100mcg 3 times per day.
I consider that
at this point of time, this lacks adequate evidence base.
CELL CYBERNETICS
AND REGULATORY DYSFUNCTION
Is there a link between immunological and inflammatory changes and metabolic
consequences?
Martin Pall, a research
biochemist at Washington State University in Pullman, Washington has
formed a hypothesis about the generation of a chemical called peroxynitrite
(PON), which would result in the chronic homeostasis of chronic fatigue.
In essence the interleukins
above induce one form of nitric oxide synthase called inducible nitric
oxide synthase (INOS). The nitric oxide which forms reacts with superoxide
in mitochondria to produce the peroxynitrite, a more reactive free radical.
Superoxides are
also a product of oxidative injury in cells in circumstances of chemical
and microbiological damage.
PEROXYNITRITE
EFFECTS.
(1) The
peroxynitrite inactivates superoxide dismutase in mitochondria increasing
the levels of superoxide.
(2) But
in addition the peroxynitrite activates a transcription factor called
nuclear factor kappa beta (NFKb) which stimulates gene transcription
for ILI, IL6, TNF alpha and IF gamma, and also gene transcription
for inducible nitric oxide synthase. (A self perpetuating cycle)
Thus both superoxide
production (and decreased degradation) and nitric oxide production
are kept high, perpetuating a higher level of peroxynitrite.
(3) Peroxynitrite
contributes to a decrease in ATP pools in the following fashion (a
further feed forward effect).
An enzyme called
poly adenylate ribose synthase is activated by breaks in DNA. Free
radicals produce "nicks" in mitochondrial and nuclear DNA.
The PARS promotes
polyribosylation of histones, and the substrate NAD involved in all
oxidative and energy metabolism conversion to NADH is depleted.
We have already
mentioned the inhibiting effects on aconitase, and other enzymes.
With depleted
NAD+/NADH, ATP is also depleted. Hence mitochondrial and perhaps nuclear
cell energetics are impaired.
(4) It
is likely that increased peroxynitrite contributes to injury in other
inflammatory states. The proximity of T cells, and other cells participating
in pathological processes, to target cell sites shapes the risk of
interleukin over-activity or oxidative injury.
It is clear that
a number of factors are involved in the location of these specific
injuries.
(5) Chromosomal
abnormalities are found in up to 90% of cases of scleroderma where
peroxynitrite is likely to be active at endothelial and sub endothelial
vascular locations.
(6) Dr
Judy Ford has reported increased chromosomal abnormalities in people
using pesticides.
(7) I believe
that we need to be much more concerned than ever about the high level
of environmental pollutants. Sufferers with chronic fatigue may represent
a more vulnerable sub group.
(8) PON
increases intracellular calcium, which is pertinent to 2 other NO
synthases, which are calcium dependent. Increased intracellular calcium
could further disadvantage cell function.
(9) NO
and PON might also facilitate rapid glutamate release in some neurological
injury states but it would be speculative to know whether the"
mind-fog" states of CFS are related to this.
OTHER ASPECTS
OF IMPAIRED ATP FUNCTION
(1) There
may be decreased transfer of free fatty acids by carnitine across
the mitochondrial membrane.
Acetyl l carnitine
is needed to transport long chain fatty acids across mitochondrial
membranes.
(2) If
magnesium is low, ATPase cellular pumps may not work as well.
FURTHER PROBABLE
PATHOPHYSIOLOGICAL CHANGES.
There are a proportion
of people with chronic fatigue syndromes who have a tendency to low
blood pressure and postural hypotension. Some also seem to exhibit a
readily provoked tachycardia.
Dr Peter Rowe from
Johns Hopkins School of Medicine in Baltimore, Maryland reports the
concepts of neurally mediated hypotension and postural orthostatic tachycardia
syndromes in chronic fatigue.
Some of these may
have a reduced blood volume and others may be prone to orthostatic blood
pooling. Perhaps vasomotor tone is altered.
Dr David Bell from
New York (also Harvard's Cambridge hospital) reports that in 45 patients
with chronic fatigue he evaluated that 68% had a decreased circulating
blood volume, 71% a reduced red cell mass, and 67% a decreased plasma
volume. There was a trend for the hypovolaemic sufferers to have an
increased plasma osmolality above 290 mOsmoles/ml and since some also
had reduced fasting urine osmolality an anti diuretic hormone deficiency
may be present.
OTHER AUSTRALIAN
STUDIES.
Dr Richard Burnet,
an Adelaide endocrinologist, as mentioned above, has found total body
potassium to be low in about 50% of C.F.S. subjects, (despite normal
serum levels).
He also finds evidence
of delayed gastric emptying in some 60% of CFS subjects.
This could account
for bloating reported by many patients.
There is also separate
work using SPECT scans on the brain revealing altered (reduced) perfusion
in some specific brain regions. (Burnet, Kwiatek and Casse)
Professor Tim Roberts,
of the Newcastle group, thinks that intracellular organisms subvert
the sterol pathway to use cholesterol to make ergosterol.
We may have to add
that toxins evoke injury to cell membranes including specific injury
to ion channels, a so called channelopathy.
Such injuries have
been demonstrated with ciguatera toxin.
Are chronic fatigue
and fibromyalgic syndromes inflammatory states?
To address this
question I will outline some recent research into something which seems
to be emerging as common in such situations as obesity and other mild
inflammatory states.
It is becoming evident
that there are many patterns of inflammation, and doctors look carefully
for evidence of inflammation in the patients history, examination
findings and by ordering common tests such as measurement of C reactive
protein (CRP), erythrocyte sedimentation rate (ESR) and fibrinogen along
with a close look at various kinds of white blood cells.
We may observe for
example that a patient has some mild gingivitis (or reports that gums
bleed a little on cleaning her or his teeth, but the CRP and ESR are
normal.
The researchers
into premature births around the world have noted the danger of the
pregnant woman having vaginal flora containing beta haemolytic streptococci.
Eradication of the
vaginal streptococci had marked ly reduced prematurity, but this is
not enough.
Now the researchers
at the Princess Margaret Hospital in Perth, Western Australia report
a further reduction of premature births by special care of gums and
mouth in pregnancy.
I believe that we
need to be this fastidious in the care of persons with CFS, and fibromyalgia
syndromes and indeed in any hard to diagnose chronic disease.
A discovery of another
inflammatory association has come with elucidation of PPAR, a family
of nuclear receptors.
Nuclear peroxisome
proliferator-activated receptors (PPARs) are ligand-activated transcription
factors belonging to the nuclear receptor superfamily. As transcription
factors, PPARs regulate the expression of numerous genes and affect
glycaemic control, lipid metabolism, vascular tone and inflammation.
Also PPAR agonists
inhibit the metalloproteinase activation in macrophage.
There is even evidence
that intestinal flora influence PPAR expression in intestinal locations.
NON SPECIFIC
INFLAMMATORY MECHANISMS.
The non-specific
inflammatory pathways may be activated in some forms of chronic fatigue
in a lesser degree than in what we call "collagen diseases".
Arachidonic acid
(an omega 6 fatty acid) in all cell membranes is released from its membrane
bound form by phospholipase A2 (more so in states of cell injury).
Active eicosanoid
metabolites generated through cyclo-oxygenase pathways are prostaglandins
of the 2 series (PGE2, G2), which increase pain and inflammation. (See
diagram)
Leucotrienes of
the 4 series, LTA4, B4, C4, D4 and E4 are generated from 5 lipoxygenase.
LTB4 increases local oedema, and is chemotactic for neutrophils and
eosinophils, while LTC4, D4 and E4 are broncho-spastic.
In some more inflammatory
conditions, the above leucocytes release enough proteases to add to
target organ damage.
When I address recent
advances in treatment of the CFS/FMS and brain fog states, I will draw
upon this material.
KEY CELL CHANGES
IN CHRONIC FATIGUE.
The above information reveals some of the ways that infection, genetic
vulnerability, inflammation, the immune system and intricate cell signalling
and biochemical pathway alterations could set a chronic homeostasis
of illness in chronic fatigue and in auto immune and collagen diseases.
In particular some subtle metabolic changes in cells may be crucial
to the striking lack of energy and the marked post exercise lassitude
that may last for hours or days.
Antinuclear antibodies
are often slightly elevated in chronic fatigue.
Peroxynitrite also
plays a role in autoimmune diseases (which themselves appear to be responses
to exogenous viral and bacterial material). We actually need to be vigilant
about these diseases, which may evolve slowly, eluding early diagnosis.
It can be seen that
abnormal gut, muscle, and neural function can be evoked with or accompanying
immune/inflammatory happenings.
The above hypothesis
remains a hypothesis but at least gives an indication of how chronic
fatigue syndromes might emerge.
Dr Sarah Myhill
<http://www.drmyhill.co.uk/>
in Wales has a plan based on correcting cell energy mechanisms. I expand
on this in Chapter 18 on the therapy of CFS.
The reader should
now be able to see that before we rush into claiming that psychological
mechanisms are the reason for symptom bearers, we have a lot or searching
to undertake.